SRN Advisors’s ResMed RMD Stock Holding History

SRN Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$227K	Sell	879 -107	-11%	-$25.5K	0.21%	94
2025 Q1	$221K	Hold	986	–	–	0.25%	98
2024 Q4	$225K	Buy	+986	New	+$237K	0.2%	98

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SRN Advisors's RMD Position: Q2 2025 in Review

SRN Advisors reduced its ResMed (RMD) stake by 11% in Q2 2025, selling an estimated $25.5K and leaving 879 shares worth $227K. The position accounts for 0.21% of the portfolio, ranked #94.

SRN Advisors first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

SRN Advisors held 879 shares of ResMed worth $227K as of Q2 2025.
SRN Advisors sold 107 ResMed shares in Q2 2025, an estimated $25.5K.
ResMed made up 0.21% of SRN Advisors's portfolio in Q2 2025, its #94 holding.
SRN Advisors first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on SRN Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.